This is the seventh special EBMT report on the indications for haematopoietic stem cell
transplantation for haematological diseases, solid tumours and immune disorders. Our aim …

Autologous haematopoietic stem cell transplantation (AHSCT) is a multistep procedure that
enables destruction of the immune system and its reconstitution from haematopoietic stem …

Importance High-dose immunosuppressive therapy and autologous hematopoietic stem cell
transplantation (HSCT) have shown efficacy in systemic sclerosis in phase 1 and small …

These updated EBMT guidelines review the clinical evidence, registry activity and
mechanisms of action of haematopoietic stem cell transplantation (HSCT) in multiple …

This is the sixth special report that the European Society for Blood and Marrow
Transplantation regularly publishes on the current practice and indications for …

The clinical outcome, response to treatment, and occurrence of acute complications were
retrospectively investigated in 308 primary autoimmune hemolytic anemia (AIHA) cases and …

Autoimmune hemolytic anemia (AIHA) is a relatively uncommon disorder caused by
autoantibodies directed against self red blood cells. It can be idiopathic or secondary, and …

Hematopoietic stem cell transplantation (HSCT) has evolved for> 20 years as a specific
treatment of patients with autoimmune disease (AD). Using European Society for Blood and …

Autoimmune diseases (ADs) represent a heterogenous group of complex diseases with
increasing incidence in Western countries and are a major cause of morbidity …

Objective: To assess in multiple sclerosis (MS) the effect of intense immunosuppression
followed by autologous hematopoietic stem cells transplantation (AHSCT) vs mitoxantrone …